SANGUINE CORP. (SGNC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: UnderCover who wrote (37)	6/4/1998 7:11:00 AM
From: Cage Rattler	Read Replies (2) of 5402

Tyler: Baxter is (was) in the competition. I found the article yesterday on the New York Times web site under Business; After reading the article I copied the headline and posted that on the thread. Some investors interested in this biotech nitch, that followed Baxter, may now turn elsewhere -- SGNC for example. In my opinion demise of a competitor in Biotechs is always favorable during early R&D and Cat I, II, and III testing -- unless the technology is similar and hopefully, that is not the case. Sorry to catch you at a loss. Ciao, Ted

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next